This funding record is inactive. Please see the program website or contact the program sponsor to determine if this program is currently accepting applications or will open again in the future.
Overdose Data to Action: Limiting Overdose through Collaborative Actions in Localities (OD2A: LOCAL)
Link
https://www.cdc.gov/drugoverdose/od2a/local.html
Additional Links
Notice of Funding Opportunity (Grants.gov)
Deadline
Letter of Intent
(Optional):
Apr 6, 2023
Application Deadline: May 8, 2023
Sponsor
Centers for Disease Control and Prevention (CDC)
Purpose
Awards funding to strengthen city or county local health departments' or their bona fide agents, special district health departments', and territorial governments' ability to use data to determine and implement actions to reduce overdose morbidity and mortality in communities, focusing on opioids and/or stimulants. Seeks to reduce health disparities and increase access to care and services for populations most at risk of overdose, including rural communities and tribal populations.
Component A is required and comprised of
core prevention and surveillance strategies.
The Prevention Component is comprised of 3 required strategies focused on:
- Linkage to and Retention in Care to connect people to services, care activities, supports for retentions in care, recovery, and re-engagement in care.
- Harm Reduction to implement strategies to increase treatment entry, reduce the frequency of drug use, and improve the overall health and wellness of persons who use drugs (PWUDs) with a focus on reducing overdoses.
- Clinician and Health Systems Best Practices to improve the clinical management of pain and substance use disorder (SUD), and build healthcare infrastructure to improve care coordination.
Optional prevention strategies include:
- Stigma Reduction
- Health IT Enhancements
The Surveillance Component is comprised of 1 required strategy focused on:
- Overdose Surveillance Infrastructure to improve and enhance the overall capacity of the grantee to conduct overdose-related surveillance.
An optional, competitive application process is available for:
- Component B - Toxicologic Testing of Drug Product and/or Paraphernalia
- Component C- Surveillance of Linkage to and Retention in Care
Additional information on the priority strategies and related activities, as well as short-, intermediate-, and long-term outcomes, is available in the program guidance.
Amount of Funding
Average 1-year award amounts:
- Component A: $2,000,000
- Component B and C: $250,000 - $325,000
Estimated number of awards: 40
Estimated total program funding: $400,000,000
Who Can Apply
City or county local health departments or their bona fide agents, special district health departments, and territorial governments are eligible to apply.
Geographic Coverage
Nationwide
What This Program Funds
Capacity Building • Operating Costs and Staffing
Application Process
Application instructions, requirements, and other information about the online application process are available in the funding announcement.
Letter of intent (LOI) requested but not required.
Contact
For programmatic or technical
questions:
Yarkasah Paye
od2a-local@cdc.gov
For grants management or budget
questions:
Darryl Mitchell
dvm1@cdc.gov
Topics This Program Addresses
Harm Reduction • Medication-Assisted Treatment (MAT) • Naloxone • Opioids • Overdose Prevention • Pain Management and Opioid Prescribing • Prevention • Recovery • Substance Use Disorder • Treatment